首页> 外文OA文献 >Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio

【2h】

Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio

机译：预处理生物标志物作为牙科碱治疗胰腺癌和5氟尿嘧啶治疗的胰腺癌患者存活的预测预测因子：中性粒细胞对淋巴细胞比Vs血小板到淋巴细胞比率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yungu Chen; Yuan Liao; Lek Man Lam; Lina He; Yiu Sing Tsang; Ying-San Di; Sheng-Tao Liang; Qing Xia;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio ivs/i Platelet-to-lymphocyte ratio [J] . Yungu Chen, Yuan Liao, Lek Man Lam, International Journal of Medical Sciences . 2020,第10期

机译：预处理生物标志物作为吉西他滨治疗和5氟尿嘧啶治疗的胰腺癌患者存活的预测预测因子：中性粒细胞至淋巴细胞比率血小板到淋巴细胞比例
2. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy [J] . WANG Dan, WU Ming, FENG Feng-zhi, 中华医学杂志（英文版） . 2013,第008期

机译：术前中性粒细胞与淋巴细胞的比率以及血小板与淋巴细胞的比率不能预测新辅助化疗和全子宫切除术治疗的宫颈癌患者的存活率
3. The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：中性粒细胞对淋巴细胞比的预后和预测作用，紫杉醇 - Bevacizumab治疗Her2阴性转移性乳腺癌患者中的血小板到淋巴细胞比和淋巴细胞对单核细胞比例
4. Machine learning of patient similarity: A case study on predicting survival in cancer patient after locoregional chemotherapy [C] . 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops . 2010

机译：患者相似性的机器学习：预测局部化疗后癌症患者生存率的案例研究
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio [O] . Yungu Chen, Yuan Liao, Lek Man Lam, 2020

机译：以吉西他滨为基础的治疗和5-氟尿嘧啶治疗的胰腺癌患者的预处理预后生物标志物是生存率的预测指标：中性粒细胞与淋巴细胞之比vs血小板与淋巴细胞之比
7. Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer [O] . Jeong Won Lee, Ki Ho Seol 2021

机译：预处理中性粒细胞到淋巴细胞比例与血小板到淋巴细胞比例相结合，作为宫颈癌的明确同时化疗后存活结果的预测因子

Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio

著录项

引文网络

相似文献

相关主题

期刊订阅